Home » Regions » Asia » Siro Clinpharm relocates corporate offices

Siro Clinpharm relocates corporate offices

Wednesday, February 18, 2015

SIRO Clinpharm, an India-based CRO, has relocated its corporate headquarters within Mumbai, India. The move allows SIRO to consolidate its position in the Indian healthcare development space.

“SIRO has a successful history in Mumbai, which has allowed it to expand regionally as well as globally. This facility will allow SIRO to house all of its functions under one roof and help us to take forward our philosophy of One Data, One Team and integrated teams, where all functions, in Mumbai and elsewhere, will work like one integrated virtual team. This will help us improve our focus on serving our clients with better efficiencies and cross-functional benefits,” said Dr. Vatsal Shah, global head, medical writing, biometrics and pharmacovigilance.

Partha Chatterjee, head of clinical research and clinical trial supplies, said, “SIRO Clinpharm continues to grow and this move gives us flexibility to scale up with the increasing client needs.”

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!